A citation-based method for searching scientific literature

Edmund Lee, William L Trepicchio, Judith L Oestreicher, Debra Pittman, Frank Wang, Francesca Chamian, Madhav Dhodapkar, James G Krueger. J Exp Med 2004
Times Cited: 662



Christi Parham, Madaline Chirica, Jacqueline Timans, Elena Vaisberg, Marilyn Travis, Jeanne Cheung, Stefan Pflanz, Rebecca Zhang, Komal P Singh, Felix Vega, Wayne To, Janet Wagner, Anne-Marie O'Farrell, Terrill McClanahan, Sandra Zurawski, Charles Hannum, Daniel Gorman, Donna M Rennick, Robert A Kastelein, Rene de Waal Malefyt, Kevin W Moore. J Immunol 2002
Times Cited: 971




List of shared articles



Times cited

Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action.
Aina Akmal Mohd Noor, Maryam Azlan, Norhanani Mohd Redzwan. Biomedicines 2022
0

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview.
Claudia Schinocca, Chiara Rizzo, Serena Fasano, Giulia Grasso, Lidia La Barbera, Francesco Ciccia, Giuliana Guggino. Front Immunol 2021
21

A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab.
Feras M Ghazawi, Farhan Mahmood, Leon Kircik, Yves Poulin, Marc Bourcier, Ronald Vender, Marni C Wiseman, Charles Lynde, Ivan V Litvinov. Front Med (Lausanne) 2021
4

Prognostic value of serum soluble interleukin-23 receptor and related T-helper 17 cell cytokines in non-small cell lung carcinoma.
Dan Liu, Shan Xing, Wan Wang, Xianzhang Huang, Haibiao Lin, Yonghe Chen, Kai Lan, Lin Chen, Fudong Luo, Sheng Qin,[...]. Cancer Sci 2020
3

Characterization of a reliable cell-based reporter gene assay for measuring bioactivities of therapeutic anti-interleukin-23 monoclonal antibodies.
Jing Huang, Lan Wang, Chuanfei Yu, Zhihao Fu, Chunyu Liu, Hongmei Zhang, Kaiqin Wang, Xiao Guo, Junzhi Wang. Int Immunopharmacol 2020
2

Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
Charlie Bridgewood, Kassem Sharif, Jonathan Sherlock, Abdulla Watad, Dennis McGonagle. Immunol Rev 2020
32


Guselkumab in the treatment of moderate-to-severe plaque psoriasis.
Cristina López-Sánchez, Lluís Puig. Immunotherapy 2020
3

Risankizumab for the treatment of moderate to severe psoriasis.
Andrea Chiricozzi, Luca Antonioli, Salvatore Panduri, Matteo Fornai, Marco Romanelli, Corrado Blandizzi. Expert Opin Biol Ther 2019
2

AS2762900-00, a potent anti-human IL-23 receptor monoclonal antibody, prevents epidermal hyperplasia in a psoriatic human skin xenograft model.
Haruna Sasaki-Iwaoka, Katsunari Taguchi, Yohei Okada, Emiko Imamura, Satoshi Kubo, Shigetada Furukawa, Tatsuaki Morokata. Eur J Pharmacol 2019
1

Association of TNF, IL12, and IL23 gene polymorphisms and psoriatic arthritis: meta-analysis.
Marco Antonio Rocha Loures, Hugo Vicentin Alves, Amarilis Giaretta de Moraes, Thaís da Silva Santos, Fernanda Formaggi Lara, Janisleya Silva Ferreira Neves, Luciana Conci Macedo, Jorge Juarez Vieira Teixeira, Ana Maria Sell, Jeane Eliete Laguila Visentainer. Expert Rev Clin Immunol 2019
9